These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32381748)

  • 1. [Cognitive Impairment in Multiple Sclerosis].
    Niino M; Miyazaki Y
    Brain Nerve; 2020 May; 72(5):509-515. PubMed ID: 32381748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cognitive impairment in multiple sclerosis].
    Niino M
    Rinsho Shinkeigaku; 2014; 54(12):1058-9. PubMed ID: 25519962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognitive Impairment in Multiple Sclerosis].
    Niino M; Miyazaki Y
    Brain Nerve; 2016 Apr; 68(4):375-81. PubMed ID: 27056855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments.
    Korakas N; Tsolaki M
    Cogn Behav Neurol; 2016 Jun; 29(2):55-67. PubMed ID: 27336803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis.
    Miller E; Morel A; Redlicka J; Miller I; Saluk J
    Curr Neuropharmacol; 2018; 16(4):475-483. PubMed ID: 29119933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in multiple sclerosis.
    Jongen PJ; Ter Horst AT; Brands AM
    Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
    Pflugshaupt T; Geisseler O; Nyffeler T; Linnebank M
    Semin Neurol; 2016 Apr; 36(2):203-11. PubMed ID: 27116727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    Porcel J; Montalban X
    J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive impairment in multiple sclerosis].
    Ochi H
    Brain Nerve; 2014 Oct; 66(10):1201-9. PubMed ID: 25296874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Aspects in Multiple Sclerosis.
    Lisak M; Špiljak B; Pašić H; Trkanjec Z
    Psychiatr Danub; 2021 Dec; 33(Suppl 13):177-182. PubMed ID: 35150483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?
    Oset M; Stasiolek M; Matysiak M
    Curr Neurol Neurosci Rep; 2020 May; 20(7):22. PubMed ID: 32444997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary results of rehabilitation intervention for the correction of cognitive impairment in patients with multiple sclerosis].
    Sivertseva SA; Belkin AA; Zotova AV; Korneeva NS; Guseva ME
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7. Vyp. 2):94-98. PubMed ID: 34387454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline.
    Wallach AI; Waltz M; Casper TC; Aaen G; Belman A; Benson L; Chitnis T; Gorman M; Graves J; Harris Y; Lotze TE; Mar S; Moodley M; Ness JM; Rensel M; Rodriguez M; Rose JW; Schreiner T; Tillema JM; Waubant E; Weinstock-Guttman B; Charvet LE; Krupp LB
    Mult Scler; 2020 Dec; 26(14):1938-1947. PubMed ID: 31775571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive impairment and social cognition in multiple sclerosis.
    Doskas T; Vavougios GD; Karampetsou P; Kormas C; Synadinakis E; Stavrogianni K; Sionidou P; Serdari A; Vorvolakos T; Iliopoulos I; Vadikolias Κ
    Int J Neurosci; 2022 Dec; 132(12):1229-1244. PubMed ID: 33527857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive impairment in multiple sclerosis: Frequent and early].
    Pelletier J
    Rev Prat; 2016 Jan; 66(1):42-43. PubMed ID: 30512398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuropsychological tests in multiple sclerosis].
    Takeda A
    Nihon Rinsho; 2014 Nov; 72(11):1989-94. PubMed ID: 25518382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in multiple sclerosis.
    Chiaravalloti ND; DeLuca J
    Lancet Neurol; 2008 Dec; 7(12):1139-51. PubMed ID: 19007738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early neuropsychological markers of cognitive involvement in multiple sclerosis.
    Eilam-Stock T; Shaw MT; Krupp LB; Charvet LE
    J Neurol Sci; 2021 Apr; 423():117349. PubMed ID: 33639421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Multiple Sclerosis and Cognition: A Review of Clinical, Neuropsychologic, and Neuroradiologic Features.
    Ekmekci O
    Behav Neurol; 2017; 2017():1463570. PubMed ID: 29434433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.